Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $24000.0.

  • Catheter Precision's Gains from Investment Securities fell 7495.12% to $24000.0 in Q3 2025 from the same period last year, while for Mar 2025 it was $1.6 million, marking a year-over-year increase of 16703.59%. This contributed to the annual value of $91000.0 for FY2024, which is N/A changed from last year.
  • Catheter Precision's Gains from Investment Securities amounted to $24000.0 in Q3 2025, which was down 7495.12% from $1.6 million recorded in Q1 2025.
  • Catheter Precision's Gains from Investment Securities' 5-year high stood at $214.7 million during Q3 2023, with a 5-year trough of $1305.0 in Q4 2022.
  • Over the past 5 years, Catheter Precision's median Gains from Investment Securities value was $106380.0 (recorded in 2022), while the average stood at $12.8 million.
  • Per our database at Business Quant, Catheter Precision's Gains from Investment Securities surged by 1504208640.5% in 2023 and then crashed by 9995.54% in 2024.
  • Catheter Precision's Gains from Investment Securities (Quarter) stood at $2094.0 in 2021, then tumbled by 37.68% to $1305.0 in 2022, then skyrocketed by 16448329.12% to $214.7 million in 2023, then tumbled by 99.96% to $91000.0 in 2024, then crashed by 73.63% to $24000.0 in 2025.
  • Its Gains from Investment Securities was $24000.0 in Q3 2025, compared to $1.6 million in Q1 2025 and $91000.0 in Q4 2024.